Why the study?
Does the Impella 2.5 device improve ventricular function in acute peripartum cardiomyopathy complicated by cardiac arrest?
Does the Impella 2.5 device improve ventricular function in acute peripartum cardiomyopathy complicated by cardiac arrest?
The Impella 2.5 device was successfully used as a bridge to recovery in a patient with acute peripartum cardiomyopathy and cardiac arrest during cesarean delivery.
May support Impella bridge-to-recovery in peripartum cardiomyopathy arrest; hypothesis-generating, requires prospective trials.
Peripartum cardiomyopathy is a rare form of heart failure with significant perioperative implications. In this case report, we describe a 34-year-old gravida 5, parity 3, patient who was admitted for an elective cesarean delivery. During the delivery, the patient developed sudden cardiac arrest and was emergently intubated in the operating room. An emergent transesophageal echocardiogram revealed a left ventricular ejection fraction of 10% with global biventricular hypokinesis. Urgent multidisciplinary consultations led to the rapid implementation of the Impella™ 2.5 for ventricular support. The patient recovered ventricular function within 4 days and recovered to baseline function.
No takes yet. Share an insight, caveat, or question.
Padilla et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: